|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 94 No. 11 (December 1), 1999:
pp. 3678-3682
Lipoprotein (a) and Genetic Polymorphisms of Clotting Factor V,
Prothrombin, and Methylenetetrahydrofolate Reductase Are Risk Factors
of Spontaneous Ischemic Stroke in Childhood
Ulrike Nowak-Göttl,
Ronald Sträter,
Achim Heinecke,
Ralf Junker,
Hans-Georg Koch,
Gerhard Schuierer, and
Arnold von
Eckardstein for the Childhood Stroke Study Group
From the Department of Paediatrics, Institute of Clinical Chemistry
and Laboratory Medicine and Institute of Arteriosclerosis Research,
Institute of Medical Statistics, and Institute of Clinical Radiology,
Westphalian Wilhelms-University Münster, Münster, Germany.
Ischemic stroke is a rare event in childhood. In approximately one
third of cases no obvious underlying cause or disorder can be detected.
We investigated the importance of genetic risk factors of venous
thromboembolism in childhood or stroke in adulthood as risk factors for
spontaneous ischemic stroke in children. One hundred forty-eight
Caucasian infants and children (aged 0.5 to 16 years) with stroke and
296 age-matched controls from the same geographic areas as the patients
were analyzed for increased lipoprotein (a) [Lp(a)] levels >30
mg/dL; for the presence of the factor V (FV) G1691A mutation, the
prothrombin (PT) G20210A variant, and the TT677 genotype of
methylenetetrahydrofolate reductase (MTHFR); and deficiencies of
protein C, protein S, and antithrombin. The following frequencies
(patients v controls), odds ratios (ORs), and confidence
intervals (CIs) of single risk factors were found: Lp(a) >30 mg/dL
(26.4% v 4.7%; OR/CI, 7.2/3.8 to 13.8; P < .0001), FV G1691A (20.2% v 4%; OR/CI, 6/2.97 to 12.1; P < .0001), protein C deficiency (6% v 0.67%; OR/CI, 9.5/2 to
44.6; P = .001), PT G20210A (6% v 1.3%; OR/CI,
4.7/1.4 to 15.6; P = .01), and the MTHFR TT677 genotype
(23.6% v 10.4%; OR/CI, 2.4/1.53 to 4.5; P < .0001).
A combination of the heterozygous FV G1691A mutation with increased
Lp(a) (n = 11) or the MTHFR TT677 genotype (n = 5) was found in
10.8% of cases, but only 0.3% of controls (OR/CI, 35.75/4.7 to 272;
P < .0001). Increased Lp (a) levels, the FV G1691A mutation,
protein C deficiency, the prothrombin G20210A variant, and the MTHFR
TT677 are important risk factors for spontaneous ischemic stroke in childhood.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. L. Maguire, G. deVeber, and P. C. Parkin
Association Between Iron-Deficiency Anemia and Stroke in Young Children
Pediatrics,
November 1, 2007;
120(5):
1053 - 1057.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Koestenberger, B. Nagel, A. Gamillscheg, W. Temmel, G. Cvirn, and A. Beitzke
Myocardial Infarction in an Adolescent: Anomalous Origin of the Left Main Coronary Artery From the Right Coronary Sinus in Association With Combined Prothrombotic Defects
Pediatrics,
August 1, 2007;
120(2):
e424 - e427.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Ozyurek, G. Balta, A. Degerliyurt, H. Parlak, S. Aysun, and A. Gurgey
Significance of Factor V, Prothrombin, MTHFR, and PAI-1 Genotypes in Childhood Cerebral Thrombosis
Clinical and Applied Thrombosis/Hemostasis,
April 1, 2007;
13(2):
154 - 160.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Skardoutsou, K. A. Voudris, S. Mastroyianni, E. Vagiakou, G. Magoufis, and P. Koukoutsakis
Moya Moya Syndrome in a Child With Pyruvate Kinase Deficiency and Combined Prothrombotic Factors
J Child Neurol,
April 1, 2007;
22(4):
474 - 478.
[Abstract]
[PDF]
|
|
|
|
|
|
|
V. Brankovic-Sreckovic, V. Milic Rasic, V. Djordjevic, M. Kuzmanovic, and S. Pavlovic
Arterial Ischemic Stroke in a Child with {beta}-Thalassemia Trait and Methylentetrahydrofolate Reductase Mutation
J Child Neurol,
February 1, 2007;
22(2):
208 - 210.
[Abstract]
[PDF]
|
|
|
|
|
|
|
N. Akar, B. Donmez, and G. Deda
FXIII Gene Val34Leu Polymorphism in Turkish Children with Cerebral Infarct
J Child Neurol,
February 1, 2007;
22(2):
222 - 224.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. V Bedarida, U. Hoffmann, and F. Tato
Acute lower limb ischemia due to thrombo-embolic arterial occlusions in two previously healthy men with markedly elevated Lp(a)
Vascular Medicine,
November 1, 2006;
11(4):
259 - 262.
[Abstract]
[PDF]
|
|
|
|
|
|
|
E. A. Vagiakou, K. A. Voudris, Y. Dimitriou, A. Skardoutsou, and S. Mastroyianni
Different Additional Risk Factors for Cerebral Infarctions Associated With the Factor V Leiden Mutation in a Family
J Child Neurol,
October 1, 2006;
21(10):
903 - 907.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. Assmann
Dyslipidaemia and global cardiovascular risk: clinical issues
Eur. Heart J. Suppl.,
October 1, 2006;
8(suppl_F):
F40 - F46.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al.
Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Circulation,
June 20, 2006;
113(24):
e873 - e923.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al.
Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Stroke,
June 1, 2006;
37(6):
1583 - 1633.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Schneppenheim and J. Greiner
Thrombosis in Infants and Children
Hematology,
January 1, 2006;
2006(1):
86 - 96.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. K. Lynch, C. J. Han, L. E. Nee, and K. B. Nelson
Prothrombotic Factors in Children With Stroke or Porencephaly
Pediatrics,
August 1, 2005;
116(2):
447 - 453.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Buyru, J. Altinisik, G. Somay, and T. Ulutin
Factor V Leiden Mutation in Cerebrovascular Disease
Clinical and Applied Thrombosis/Hemostasis,
July 1, 2005;
11(3):
339 - 342.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F. Andreotti and R. C. Becker
Atherothrombotic Disorders: New Insights From Hematology
Circulation,
April 12, 2005;
111(14):
1855 - 1863.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S Haywood, R Liesner, S Pindora, and V Ganesan
Thrombophilia and first arterial ischaemic stroke: a systematic review
Arch. Dis. Child.,
April 1, 2005;
90(4):
402 - 405.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Saxena, M. Ranalli, N. Khan, C. Blanchong, and S. B. Kahwash
Fatal Stroke in a Child with Severe Iron Deficiency Anemia and Multiple Hereditary Risk Factors for Thrombosis
Clinical Pediatrics,
March 1, 2005;
44(2):
175 - 180.
[PDF]
|
|
|
|
|
|
|
R. Duran, B. Biner, M. Demir, C. Celtik, and S. Karasalihoglu
Factor V Leiden Mutation and Other Thrombophilia Markers in Childhood Ischemic Stroke
Clinical and Applied Thrombosis/Hemostasis,
January 1, 2005;
11(1):
83 - 88.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B. Voetsch and J. Loscalzo
Genetic Determinants of Arterial Thrombosis
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2004;
24(2):
216 - 229.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
K. Kurnik, A. Kosch, R. Strater, R. Schobess, C. Heller, and U. Nowak-Gottl
Recurrent Thromboembolism in Infants and Children Suffering From Symptomatic Neonatal Arterial Stroke: A Prospective Follow-Up Study
Stroke,
December 1, 2003;
34(12):
2887 - 2892.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Marcovina, M. L. Koschinsky, J. J. Albers, and S. Skarlatos
Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent Advances and Future Directions
Clin. Chem.,
November 1, 2003;
49(11):
1785 - 1796.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. Bjorke Monsen and P. M. Ueland
Homocysteine and methylmalonic acid in diagnosis and risk assessment from infancy to adolescence
Am. J. Clinical Nutrition,
July 1, 2003;
78(1):
7 - 21.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. S. Donahue, D. Gailani, M. S. Higgins, D. C. Drinkwater, and A. L. George Jr
Factor V Leiden Protects Against Blood Loss and Transfusion After Cardiac Surgery
Circulation,
February 25, 2003;
107(7):
1003 - 1008.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Austin, M. I. Chimowitz, H. A. Hill, S. Chaturvedi, L. R. Wechsler, R. J. Wityk, E. Walz, J. L. Wilterdink, B. Coull, C. A. Sila, et al.
Cryptogenic Stroke in Relation to Genetic Variation in Clotting Factors and Other Genetic Polymorphisms Among Young Men and Women * Editorial Comment
Stroke,
December 1, 2002;
33(12):
2762 - 2768.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. deVeber, A. Chan, U. Nowak-Gottl, and R. Strater
Aspirin Versus Low-Molecular-Weight Heparin for Ischemic Stroke in Children: An Unanswered Question * Response
Stroke,
August 1, 2002;
33(8):
1947 - 1948.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Deda, D. Icagasioglu, H. Qaksen, and N. Akar
Combined Genetic Defects in a Child With Ischemic Stroke: Case Report
J Child Neurol,
July 1, 2002;
17(7):
533 - 534.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. Juul, A. Tybjarg-Hansen, R. Steffensen, S. Kofoed, G. Jensen, and B. G. Nordestgaard
Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses
Blood,
June 17, 2002;
100(1):
3 - 10.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Strater, K. Kurnik, C. Heller, R. Schobess, P. Luigs, and U. Nowak-Gottl
Aspirin Versus Low-Dose Low-Molecular-Weight Heparin: Antithrombotic Therapy in Pediatric Ischemic Stroke Patients: A Prospective Follow-Up Study
Stroke,
November 1, 2001;
32(11):
2554 - 2558.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Nowak-Gottl, R. Junker, W. Kreuz, A. von Eckardstein, A. Kosch, N. Nohe, R. Schobess, and S. Ehrenforth
Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors
Blood,
February 15, 2001;
97(4):
858 - 862.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. von Depka, U. Nowak-Gottl, R. Eisert, C. Dieterich, M. Barthels, I. Scharrer, A. Ganser, and S. Ehrenforth
Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism
Blood,
November 15, 2000;
96(10):
3364 - 3368.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Gunther, R. Junker, R. Strater, R. Schobess, K. Kurnik, A. Kosch, U. Nowak-Gottl, and f. t. C. S. S. Group
Symptomatic Ischemic Stroke in Full-Term Neonates : Role of Acquired and Genetic Prothrombotic Risk Factors
Stroke,
October 1, 2000;
31(10):
2437 - 2441.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Kenet, S. Sadetzki, H. Murad, U. Martinowitz, N. Rosenberg, S. Gitel, G. Rechavi, and A. Inbal
Factor V Leiden and Antiphospholipid Antibodies Are Significant Risk Factors for Ischemic Stroke in Children
Stroke,
June 1, 2000;
31(6):
1283 - 1288.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. J. Kirkham, M. Prengler, D. K.M. Hewes, and V. Ganesan
Risk Factors for Arterial Ischemic Stroke in Children
J Child Neurol,
May 1, 2000;
15(5):
299 - 307.
[Abstract]
[PDF]
|
|
|
| |
